PROSUS NV (PRX.AS) Fundamental Analysis & Valuation

AMS:PRX • NL0013654783

Current stock price

40.77 EUR
-0.76 (-1.84%)
Last:

This PRX.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. PRX.AS Profitability Analysis

1.1 Basic Checks

  • In the past year PRX was profitable.
  • PRX had a positive operating cash flow in the past year.
  • In the past 5 years PRX has always been profitable.
  • In multiple years PRX reported negative operating cash flow during the last 5 years.
PRX.AS Yearly Net Income VS EBIT VS OCF VS FCFPRX.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

1.2 Ratios

  • PRX has a Return On Assets of 16.85%. This is amongst the best in the industry. PRX outperforms 92.86% of its industry peers.
  • PRX has a Return On Equity of 24.24%. This is in the better half of the industry: PRX outperforms 78.57% of its industry peers.
  • PRX has a Return On Invested Capital of 0.27%. This is in the lower half of the industry: PRX underperforms 71.43% of its industry peers.
Industry RankSector Rank
ROA 16.85%
ROE 24.24%
ROIC 0.27%
ROA(3y)14.42%
ROA(5y)16.58%
ROE(3y)20.97%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
PRX.AS Yearly ROA, ROE, ROICPRX.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

1.3 Margins

  • PRX has a Profit Margin of 196.38%. This is amongst the best in the industry. PRX outperforms 100.00% of its industry peers.
  • PRX's Profit Margin has improved in the last couple of years.
  • With a Operating Margin value of 3.87%, PRX is not doing good in the industry: 64.29% of the companies in the same industry are doing better.
  • PRX has a Gross Margin (45.21%) which is comparable to the rest of the industry.
  • PRX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.87%
PM (TTM) 196.38%
GM 45.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.61%
PM growth 5Y12.1%
GM growth 3Y20.87%
GM growth 5Y4.2%
PRX.AS Yearly Profit, Operating, Gross MarginsPRX.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300 400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. PRX.AS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PRX is destroying value.
  • The number of shares outstanding for PRX has been reduced compared to 1 year ago.
  • Compared to 5 years ago, PRX has more shares outstanding
  • The debt/assets ratio for PRX has been reduced compared to a year ago.
PRX.AS Yearly Shares OutstandingPRX.AS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
PRX.AS Yearly Total Debt VS Total AssetsPRX.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • PRX has an Altman-Z score of 4.06. This indicates that PRX is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.06, PRX is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
  • The Debt to FCF ratio of PRX is 9.30, which is on the high side as it means it would take PRX, 9.30 years of fcf income to pay off all of its debts.
  • PRX has a Debt to FCF ratio (9.30) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.30 indicates that PRX is not too dependend on debt financing.
  • The Debt to Equity ratio of PRX (0.30) is better than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.3
Altman-Z 4.06
ROIC/WACC0.04
WACC7.44%
PRX.AS Yearly LT Debt VS Equity VS FCFPRX.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B 40B 50B

2.3 Liquidity

  • PRX has a Current Ratio of 3.66. This indicates that PRX is financially healthy and has no problem in meeting its short term obligations.
  • PRX has a better Current ratio (3.66) than 92.86% of its industry peers.
  • A Quick Ratio of 3.62 indicates that PRX has no problem at all paying its short term obligations.
  • The Quick ratio of PRX (3.62) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.66
Quick Ratio 3.62
PRX.AS Yearly Current Assets VS Current LiabilitesPRX.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. PRX.AS Growth Analysis

3.1 Past

  • PRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 87.14%, which is quite impressive.
  • Measured over the past years, PRX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.24% on average per year.
  • The Revenue has grown by 16.28% in the past year. This is quite good.
  • Measured over the past years, PRX shows a quite strong growth in Revenue. The Revenue has been growing by 13.13% on average per year.
EPS 1Y (TTM)87.14%
EPS 3Y-3.39%
EPS 5Y17.24%
EPS Q2Q%35.96%
Revenue 1Y (TTM)16.28%
Revenue growth 3Y-0.36%
Revenue growth 5Y13.13%
Sales Q2Q%22.27%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.60% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 16.04% on average over the next years. This is quite good.
EPS Next Y28.18%
EPS Next 2Y22.76%
EPS Next 3Y20.65%
EPS Next 5Y11.6%
Revenue Next Year40.37%
Revenue Next 2Y32.03%
Revenue Next 3Y26.2%
Revenue Next 5Y16.04%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PRX.AS Yearly Revenue VS EstimatesPRX.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B
PRX.AS Yearly EPS VS EstimatesPRX.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

7

4. PRX.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 8.17 indicates a reasonable valuation of PRX.
  • PRX's Price/Earnings ratio is rather cheap when compared to the industry. PRX is cheaper than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.35, PRX is valued rather cheaply.
  • A Price/Forward Earnings ratio of 9.64 indicates a reasonable valuation of PRX.
  • 92.86% of the companies in the same industry are more expensive than PRX, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of PRX to the average of the S&P500 Index (22.23), we can say PRX is valued rather cheaply.
Industry RankSector Rank
PE 8.17
Fwd PE 9.64
PRX.AS Price Earnings VS Forward Price EarningsPRX.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PRX is valued a bit more expensive than 78.57% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of PRX indicates a somewhat cheap valuation: PRX is cheaper than 64.29% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 59.44
EV/EBITDA 309.14
PRX.AS Per share dataPRX.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • PRX's earnings are expected to grow with 20.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.29
PEG (5Y)0.47
EPS Next 2Y22.76%
EPS Next 3Y20.65%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. PRX.AS Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.48%, PRX is not a good candidate for dividend investing.
  • PRX's Dividend Yield is a higher than the industry average which is at 0.48.
  • Compared to an average S&P500 Dividend Yield of 1.82, PRX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.48%

5.2 History

  • The dividend of PRX decreases each year by -19.73%.
Dividend Growth(5Y)-19.73%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • PRX pays out 2.00% of its income as dividend. This is a sustainable payout ratio.
DP2%
EPS Next 2Y22.76%
EPS Next 3Y20.65%
PRX.AS Yearly Income VS Free CF VS DividendPRX.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B
PRX.AS Dividend Payout.PRX.AS Dividend Payout, showing the Payout Ratio.PRX.AS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

PRX.AS Fundamentals: All Metrics, Ratios and Statistics

PROSUS NV

AMS:PRX (4/27/2026, 7:00:00 PM)

40.77

-0.76 (-1.84%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)11-24
Earnings (Next)N/A
Inst Owners63.03%
Inst Owner ChangeN/A
Ins Owners0.8%
Ins Owner ChangeN/A
Market Cap96.99B
Revenue(TTM)6.83B
Net Income(TTM)13.41B
Analysts81.67
Price Target66.7 (63.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.48%
Yearly Dividend0.04
Dividend Growth(5Y)-19.73%
DP2%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.42%
PT rev (3m)-1.33%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.02%
EPS NY rev (3m)4.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.6%
Revenue NY rev (3m)6.47%
Valuation
Industry RankSector Rank
PE 8.17
Fwd PE 9.64
P/S 16.63
P/FCF 59.44
P/OCF 56.4
P/B 2.05
P/tB 2.21
EV/EBITDA 309.14
EPS(TTM)4.99
EY12.24%
EPS(NY)4.23
Fwd EY10.37%
FCF(TTM)0.69
FCFY1.68%
OCF(TTM)0.72
OCFY1.77%
SpS2.45
BVpS19.86
TBVpS18.48
PEG (NY)0.29
PEG (5Y)0.47
Graham Number47.2238 (15.83%)
Profitability
Industry RankSector Rank
ROA 16.85%
ROE 24.24%
ROCE 0.36%
ROIC 0.27%
ROICexc 0.29%
ROICexgc 0.3%
OM 3.87%
PM (TTM) 196.38%
GM 45.21%
FCFM 27.98%
ROA(3y)14.42%
ROA(5y)16.58%
ROE(3y)20.97%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.61%
PM growth 5Y12.1%
GM growth 3Y20.87%
GM growth 5Y4.2%
F-Score7
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.3
Debt/EBITDA 40.19
Cap/Depr 70.55%
Cap/Sales 1.51%
Interest Coverage 0.46
Cash Conversion 491.22%
Profit Quality 14.25%
Current Ratio 3.66
Quick Ratio 3.62
Altman-Z 4.06
F-Score7
WACC7.44%
ROIC/WACC0.04
Cap/Depr(3y)83.48%
Cap/Depr(5y)79.69%
Cap/Sales(3y)2.75%
Cap/Sales(5y)2.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.14%
EPS 3Y-3.39%
EPS 5Y17.24%
EPS Q2Q%35.96%
EPS Next Y28.18%
EPS Next 2Y22.76%
EPS Next 3Y20.65%
EPS Next 5Y11.6%
Revenue 1Y (TTM)16.28%
Revenue growth 3Y-0.36%
Revenue growth 5Y13.13%
Sales Q2Q%22.27%
Revenue Next Year40.37%
Revenue Next 2Y32.03%
Revenue Next 3Y26.2%
Revenue Next 5Y16.04%
EBIT growth 1Y576.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year375.95%
EBIT Next 3Y105.37%
EBIT Next 5Y139.61%
FCF growth 1Y289.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y217.17%
OCF growth 3YN/A
OCF growth 5YN/A

PROSUS NV / PRX.AS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for PROSUS NV?

ChartMill assigns a fundamental rating of 6 / 10 to PRX.AS.


What is the valuation status of PROSUS NV (PRX.AS) stock?

ChartMill assigns a valuation rating of 7 / 10 to PROSUS NV (PRX.AS). This can be considered as Undervalued.


How profitable is PROSUS NV (PRX.AS) stock?

PROSUS NV (PRX.AS) has a profitability rating of 5 / 10.


What are the PE and PB ratios of PROSUS NV (PRX.AS) stock?

The Price/Earnings (PE) ratio for PROSUS NV (PRX.AS) is 8.17 and the Price/Book (PB) ratio is 2.05.


What is the financial health of PROSUS NV (PRX.AS) stock?

The financial health rating of PROSUS NV (PRX.AS) is 7 / 10.